ATI Week 7: The Hematologic System Flashcards
A client is about to start taking liquid ferrous sulfate to treat iron deficiency anemia. Which of the following instructions should you include when talking with the client about taking this drug?
- Drink it through a straw
- Dilute it first with water
- Take it with food
A client is about to start taking cyanocobalamin, a vitamin B12 preparation. You understand that this drug treats which of the following types of anemia?
Pernicious
Therapeutic effect of: Factor VIII (8)
Hemophilia A
Therapeutic effect of: Folic Acid
Megaloblastic anemia
Therapeutic effect of: Heparin
Deep vein thrombosis
Therapeutic effect of: Filgrastim
Chronic neutropenia
Before administering IV folic acid, you should explain to the client that this drug can cause which of the following A/E?
Rash
You are reviewing the history of a client who is about to start therapy with Factor VIII to treat hemophilia A. Which of the following drugs the client takes should alert you to take further action?
Aspirin
A client is about to start taking warfarin to prevent venous thrombosis. You should explain to the client that taking this drug initially requires daily blood samples to monitor the results of which of the following lab tests?
PT / NR
You are caring for a client who is receiving alteplase to dissolve a thrombus. Which of the following should you include in your care plan for this client?
- Monitor temperature
- Limit venipunctures
- Assess neurologic status
- Apply pressure to oozing sites
Pharmacologic action of: Alteplase
Dissolves blood clots
Pharmacologic action of: Filgrastim
Stimulates leukocyte production
Pharmacologic action of: Epoetin alfa
Stimulates RBC production
Pharmacologic action of: Clopidogrel
Inhibits platelet aggregation
A client is about to start taking clopidogrel to prevent transient ischemic attacks. You should instruct the client to watch and report for which of the following adverse effects of this drug?
- Petechiae
- Weakness
- Vision changes
A client is about to start taking oprelvekin for thrombocytopenia. To assess for A/E of this drug, you should monitor for which of the following carefully during drug therapy?
ECG